Abstract
Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq®, a New Generation Recombinant FVIII of Human Origin
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have